Showing results (11-20 of 44) with videos related to
Sort By:
Pageof 5
Pediatric Blood & Cancer|May 5, 2018
Multifactorial analysis of opsoclonus-myoclonus syndrome etiology ("Tumor" vs. "No tumor") in a cohort of 356 US childrenMichael R Pranzatelli, Elizabeth D Tate, Nathan R McGeeFrontiers in Neurology|September 30, 2017
Demographic, Clinical, and Immunologic Features of 389 Children with Opsoclonus-Myoclonus Syndrome: A Cross-sectional StudyMichael R Pranzatelli, Elizabeth D Tate, Nathan R McGeeEuropean Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|March 21, 2018
Effect of low-dose cyclophosphamide, ACTH, and IVIG combination immunotherapy on neuroinflammation in pediatric-onset OMS: A retrospective pilot studyMichael R Pranzatelli, Tyler J Allison, Elizabeth D TateJournal of the Neurological Sciences|October 10, 2017
Microglial/macrophage markers CHI3L1, sCD14, and sCD163 in CSF and serum of pediatric inflammatory and non-inflammatory neurological disorders: A case-control study and reference rangesMichael R Pranzatelli, Elizabeth D Tate, Nathan R McGeePediatrics|December 17, 2004
Immunologic and clinical responses to rituximab in a child with opsoclonus-myoclonus syndromeMichael R Pranzatelli, Elizabeth D Tate, Anna L Travelstead, et al.Pediatric Blood & Cancer|May 28, 2011
Ofatumumab for a rituximab-allergic child with chronic-relapsing paraneoplastic opsoclonus-myoclonusMichael R Pranzatelli, Elizabeth D Tate, Shalini Shenoy, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 11, 2013
Pediatric reference ranges for proinflammatory and anti-inflammatory cytokines in cerebrospinal fluid and serum by multiplexed immunoassayMichael R Pranzatelli, Elizabeth D Tate, Nathan R McGee, et al.Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses|December 3, 2004
Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndromeElizabeth D Tate, Tyler J Allison, Michael R Pranzatelli, et al.Pediatric Neurology|September 11, 2018
Evaluation of Responsiveness to Reduced-Dose Rituximab in Corticotropin/Intravenous Immunoglobulin/Rituximab Combination Immunotherapy for Opsoclonus-Myoclonus SyndromeMichael R Pranzatelli, Elizabeth D Tate, Nathan R McGee, et al.Journal of Clinical Immunology|October 20, 2009
Long-term cerebrospinal fluid and blood lymphocyte dynamics after rituximab for pediatric opsoclonus-myoclonusMichael R Pranzatelli, Elizabeth D Tate, Anna L Travelstead, et al.Pageof 5